Treace Medical Concepts
TMCI
123 hedge funds and large institutions have $895M invested in Treace Medical Concepts in 2023 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 58 increasing their positions, 25 reducing their positions, and 14 closing their positions.
671% more call options, than puts
Call options by funds: $15.2M | Put options by funds: $1.97M
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
132% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 25
114% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 14
44% more capital invested
Capital invested by funds: $621M → $895M (+$274M)
15% more funds holding
Funds holding: 107 → 123 (+16)
6.76% more ownership
Funds ownership: 51.34% → 58.1% (+6.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$25.5M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13.5M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$12.7M |
| 4 |
PA
Perceptive Advisors
New York
|
+$11.6M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$9.99M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
-$12.6M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$5.63M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$3.83M |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$3.22M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
-$2.85M |
TMCI Hedge Fund Activity: Q1 2023 in Review
123 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q1 2023, worth a combined $895M — up 44% from $621M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new TMCI positions and 14 closed out — a net gain of 16 holders — while 58 added to existing stakes and 25 trimmed.
The largest buyer was Loomis, Sayles & Company, opening a new position worth an estimated $25.5M. The largest seller was Janus Henderson Group, cutting an estimated $12.6M.
- 123 institutional investors held Treace Medical Concepts (TMCI) as of Q1 2023, up from 107 in Q4 2022.
- Funds reported $895M of Treace Medical Concepts stock for Q1 2023, up 44% quarter-over-quarter.
- 30 funds opened new Treace Medical Concepts positions in Q1 2023 and 14 closed out, a net change of +16 holders.
- The largest Treace Medical Concepts buyer in Q1 2023 was Loomis, Sayles & Company, an estimated $25.5M added.
- The largest Treace Medical Concepts seller in Q1 2023 was Janus Henderson Group, an estimated $12.6M sold.
Based on aggregated 13F filings for Q1 2023.